> Home / Bibliographica

Bibliographica

Vous retrouverez dans cette page les liens vers les articles que nous jugeons d'intéret lors de notre veille bibliographique.
Ces liens sont régulièrement diffusés dans les actualités intitulées BIBLIOGRAPHICA

 
BIBLIOGRAPHICA n°1 30-03-2017

Rensing-Ehl A, Pannicke U, Zimmermann SY, Lorenz MR, Neven B, Fuchs I et al. Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome. Blood. 2015 Oct 15;126(16):1967-9 (PUBMED - Site de la revue)

Allenspach E, Torgerson TR. Autoimmunity and Primary Immunodeficiency Disorders. J Clin Immunol. 2016 May;36 Suppl 1:57-67 (PUBMED - Site de la revue).

Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, et al. Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes. Pediatric blood & cancer. 2016 (PUBMED - Site de la revue)

Miano M, Ramenghi U, Russo G, Rubert L, Barone A, Tucci F et al. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. Br J Haematol. 2016 Nov;175(3):490-495 (PUBMED - Site de la revue).

Sacri AS, Bruwier A, Baujat G, Breton S, Blanche S, Briggs TA, Bader-Meunier B. Childhood-onset autoimmune cytopenia as the presenting feature of biallelic ACP5 mutations. Pediatr Blood Cancer. 2017 Feb;64(2):306-310 (PUBMED - Site de la revue).


BIBLIOGRAPHICA n°2 26-04-2017

Burness CB, Keating GM, Garnock-Jones KP. Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia. Drugs. 2016 May;76(8):869-78. doi: 10.1007/s40265-016-0581-4. (PUBMED - Site de la revue)

Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI et al. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.Hematology. 2017 Apr 17:1-9. doi: 10.1080/10245332.2017.1311442. [Epub ahead of print] (PUBMED - Site de la revue).


BIBLIOGRAPHICA n°3 01-06-2017

A practical guide to the use of eltrombopag in children with chronic immune thrombocytopenia. Grainger JD, Thind S. Pediatr Hematol Oncol. 2017 May 24:1-17. doi: 10.1080/08880018.2017.1313918. (PUBMED - Site de la revue

Epidemiology and management of primary immune thrombocytopenia: A nationwide population-based study in Korea. Lee JY, Lee JH, Lee H, Kang B, Kim JW, Kim SH et al. Thromb Res. 2017 May 11;155:86-91. doi: 10.1016/j.thromres.2017.05.010. (PUBMED - Site de la revue
 
Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology. Miano M, Ramenghi U, Russo G, Rubert L, Barone A, Tucci Fet al. Br J Haematol. 2016 Nov;175(3):490-495. doi: 10.1111/bjh.14261. Epub 2016 Jul 22. (PUBMED - Site de la revue)


BIBLIOGRAPHICA n°4 12-09-2017

Bennett CM, Neunert C, Grace RF, Buchanan G, Imbach P, Vesely SK, et al. Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants. Pediatr Blood Cancer. 2017 Aug 9. doi: 10.1002/pbc.26736 (PUBMED - Site de la revue).
 
Li Y, Zhang J, Liang Y, Ai Y, Xie J, Zheng W. Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review. Expert Opin Pharmacother. 2017 Aug 28. doi: 10.1080/14656566.2017.1373091 (PUBMED - Site de la revue).
 
Okubo Y, Michihata N, Morisaki N, Hangai M, Matsui H, Fushimi K et al. Recent trends in practice patterns and comparisons between immunoglobulin and corticosteroid in pediatric immune thrombocytopenia. Int J Hematol. 2017 Aug 28. doi: 10.1007/s12185-017-2322-1 (PUBMED - Site de la revue).


BIBLIOGRAPHICA n°5 20-11-2017

Azizi G, Tavakol M, Rafiemanesh H, Kiaee F, Yazdani R, Heydari A et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017 Oct 1 (PUBMED - Site de la revue).
 
Uzzan M, Sawalha AHD, Treton X, Gérard L, Mahévas M, Cosnes J, Amiot A. Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort. Dig Liver Dis. 2017 Apr;49(4):397-404. (PUBMED - Site de la revue).
 
Sawalh.a AH. The innate and adaptive immune response are both involved in drug-induced autoimmunity. Arthritis Rheumatol. 2017 Nov 9. (PUBMED - Site de la revue).
 
Tsuda H, Tsuji T, Tsuji M, Yamasaki H. Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients. Ann Hematol. 2017 Nov;96(11):1915-1920. (PUBMED - Site de la revue).
 
Ivison S,  Des Rosiers C, Lesage S, Rioux JD, Levings MK. Biomarker-guided stratification of autoimmune patients for biologic therapy. Curr Opin Immunol. 2017 Oct 17;49:56-63. (PUBMED - Site de la revue).


BIBLIOGRAPHICA n°6 05-03-2018

Makis A, Gkoutsias A, Palianopoulos T, Pappa E, Papapetrou E, Tsaousi C et al. Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis. Adv Hematol. 2017 2017:7878605 (PUBMED - Site de la revue)

Guo JC, Zheng Y, Chen HT, Zhou H, Huang XH, Zhong LP et al. Efficacy and safety of thrombopoietin receptor agonists in children with chronic immune thrombocytopenia: a meta-analysis. Oncotarget. 2017 Dec 19;9(6):7112-7125. (PUBMED - Site de la revue)
 
Zhang J, Liang Y, Ai Y, Li X, Xie J, Li Y, Zheng W, He R. Eltrombopag versus romiplostim in treatment of children with persistent or chronic immune thrombocytopenia: a systematic review incorporating an indirect-comparison meta-analysis. Sci Rep. 2018 Jan 12;8(1):576. (PUBMED - Site de la revue)
 
Okubo Y, Handa A. Nationwide Trend Analysis of Pediatric Inpatients With Immune Thrombocytopenia in the United States. J Pediatr Hematol Oncol. 2018 Jan 12. (PUBMED - Site de la revue)
 
Kim TO, Despotovic J, Lambert MP. Eltrombopag for use in children with immune thrombocytopenia. Blood Adv. 2018 Feb 27;2(4):454-461. (PUBMED - Site de la revue)
 
Rodeghiero F. A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.Br J Haematol. 2018 Feb 26. (PUBMED - Site de la revue)
 
Besnard C, Levy E, Aladjidi N, Stolzenberg MC, Magerus-Chatinet A, Alibeu et al. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.       Clin Immunol. 2018 Mar;188:52-57. (PUBMED - Site de la revue)


BIBLIOGRAPHICA n°7 07-06-2018
 
Kiyota K, Yoshiura KI, Houbara R, Miyahara H, Korematsu S, Ihara K. Auto-immune disorders in a child with PIK3CD variant and 22q13 deletion. Eur J Med Genet. 2018 Apr 17. (PUBMED - Site de la revue)
 
Gudbrandsdottir S, Ghanima W, Nielsen CH, Feng X, Hasselbalch HC, Bussel J. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP). Platelets. 2017 Jul;28(5):478-483. (PUBMED - Site de la revue)
 
Schifferli A, Holbro A, Chitlur M, Coslovsky M, Imbach P. A comparative prospective observational study of children and adults with immune thrombocytopenia: 2-year follow-up. Am J Hematol. 2018 Mar 8. (PUBMED - Site de la revue)
 
Grace RF, Despotovic JM, Bennett CM, Bussel JB, Neier M et al. Physician Decision Making in Selection of Second-Line Treatments in Immune Thrombocytopenia in Children. Am J Hematol. 2018 Apr 16. (PUBMED - Site de la revue)
 
Miano M, Rotulo GA, Palmisani E, Giaimo M, Fioredda F et al. Sirolimus as a rescue therapy in children with immune thrombocytopenia refractory to mycophenolate mofetil. Am J Hematol. 2018 Apr 20. (PUBMED - Site de la revue)
 
Kalfon S, Hamadeh H, Schachter Y, Sharon N. Cutaneous Hemorrhage Types as Supportive Factors for Predicting Chronic Immune Thrombocytopenia in Children. J Pediatr Hematol Oncol. 2018 Apr 17. (PUBMED - Site de la revue)
 
Bhatt NS, Bhatt P, Donda K, Dapaah-Siakwan F, Chaudhari R et al. Temporal trends of splenectomy in pediatric hospitalizations with immune thrombocytopenia. Pediatr Blood Cancer. 2018 Apr 10 (PUBMED - Site de la revue)
 
Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J. "Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children. J Pediatr Hematol Oncol. 2018 Apr 3. (PUBMED - Site de la revue)
 
Matsushita M, Pearce EJ. Disrupting metabolism to treat autoimmunity. Science. 2018 Apr 27 (PUBMED - Site de la revue)


BIBLIOGRAPHICA n°8 02-07-2018

Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene. 2018 May 15. (PUBMED - Site de la revue)
 
Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer. 2018 Jun 1:e27260 (PUBMED - Site de la revue)
 
Goulielmos GN, Zervou MI, Vazgiourakis VM, Ghodke-Puranik Y, Garyfallos A, Niewold TB. The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry. Gene. 2018 May 15. (PUBMED - Site de la revue)
 
Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer. 2018 Jun 1:e27260 (PUBMED - Site de la revue)
 
Heitink-Pollé KMJ, Uiterwaal CSPM, Porcelijn L, Tamminga RYJ, Smiers FJ, van Woerden NL et al. Intravenous immunoglobulin versus observation in childhood immune thrombocytopenia: a randomized controlled trial. Blood. 2018 Jun 26. (PUBMED - Site de la revue)
 
Rotz SJ, Ware RE, Kumar A. Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults. Pediatr Blood Cancer. 2018 Jun 1:e27260 (PUBMED - Site de la revue)


BIBLIOGRAPHICA n°9 13-08-2018

Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):400-405. (PUBMED - Site de la revue)
 
Agnelli Giacchello J, Valeri F, Boccadoro M, Borchiellini A. Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia. Eur J Haematol. 2018 Mar;100(3):304-307. (PUBMED - Site de la revue)
 
Higashide Y, Hori T, Yoto Y, Kabutoya H, Honjo S, Sakai Y et al. Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura. Pediatr Int. 2018 Apr;60(4):357-361. (PUBMED - Site de la revue)
 
Ahmed AR, Kaveri S. Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin. Front Immunol. 2018 Jul 18;9:1189 (PUBMED - Site de la revue)
 
Kanhai D, Mulder R, Ploos van Amstel HK, Schutgens R, Lukens M, Tamminga RYJ. Familial macrothrombocytopenia due to a double mutation in cis in the alpha-actinin 1 gene (ACTN1), previously considered to be chronic immune thrombocytopenic purpura. Pediatr Blood Cancer. 2018 Aug 19:e27418. . (PUBMED - Site de la revue)
 
Howie HL, Hudson KE. Murine models of autoimmune hemolytic anemia. Curr Opin Hematol. 2018 Aug 30. (PUBMED - Site de la revue)
 
Araki R, Nishimura R, Kuroda R, Fujiki T, Mase S, Noguchi et al. A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP). Int J Hematol. 2018 Aug;108(2):151-160 . (PUBMED - Site de la revue)


News


Publication de notre travail sur l'incidence de l'AHAI pédiatrique en Aquitaine

+

BIBLIOGRAPHICA 9
Veille bibliographique sur les cytopénies auto-immunes de l'enfant...mais pas que!
+

Rentrée Scolaire 2017 - PAI

+
See all news